PREPL

prolyl endopeptidase like

Basic information

Region (hg38): 2:44316281-44361862

Links

ENSG00000138078NCBI:9581OMIM:609557HGNC:30228Uniprot:Q4J6C6AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypotonia-cystinuria syndrome (Strong), mode of inheritance: AR
  • myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
  • myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
  • myasthenic syndrome, congenital, 22 (Moderate), mode of inheritance: AR
  • myasthenic syndrome, congenital, 22 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Myasthenic syndrome, congenital 22ARNeurologicMedical treatment with acetylcholine esterase inhibitors has been described as beneficial in one individual; In infancy, the use of apnea monitors may be indicated; Agents that affect neuromuscular transmission and exacerbate myasthenic manifestations should be avoidedNeurologic24610330

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PREPL gene.

  • Myasthenic syndrome, congenital, 22 (16 variants)
  • Cystinuria (6 variants)
  • Cystine urolithiasis (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PREPL gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
140
clinvar
3
clinvar
146
missense
1
clinvar
283
clinvar
10
clinvar
6
clinvar
300
nonsense
6
clinvar
5
clinvar
1
clinvar
12
start loss
3
clinvar
3
frameshift
11
clinvar
4
clinvar
15
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
11
clinvar
11
splice region
16
30
2
48
non coding
6
clinvar
5
clinvar
30
clinvar
81
clinvar
43
clinvar
165
Total 23 26 322 231 52

Highest pathogenic variant AF is 0.0000132

Variants in PREPL

This is a list of pathogenic ClinVar variants found in the PREPL region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-44319992-A-G Benign (Aug 20, 2019)1291996
2-44320003-A-G Benign (Aug 20, 2019)1228567
2-44320097-G-C Benign (Dec 01, 2020)1242368
2-44320183-T-C Cystinuria Likely benign (Dec 13, 2021)2041653
2-44320188-T-A Cystinuria Benign (Apr 20, 2023)2052092
2-44320194-A-T Cystinuria Likely benign (Oct 15, 2023)2915329
2-44320207-G-T Cystinuria Uncertain significance (Jan 12, 2018)336208
2-44320221-C-A Cystinuria Pathogenic (Jul 28, 2023)2734176
2-44320221-C-T Cystine urolithiasis • Cystinuria • SLC3A1-related disorder Conflicting classifications of pathogenicity (Dec 04, 2023)804198
2-44320222-G-T Cystinuria Conflicting classifications of pathogenicity (Apr 03, 2018)747033
2-44320234-A-G Cystinuria Likely benign (Mar 12, 2023)2709497
2-44320238-C-G Cystinuria Uncertain significance (May 22, 2022)1687510
2-44320265-G-C Cystinuria Uncertain significance (Aug 16, 2023)2734177
2-44320279-CAG-C Cystinuria Pathogenic (May 17, 2022)1071553
2-44320282-G-A Likely benign (Sep 22, 2017)711667
2-44320282-G-T Cystinuria Uncertain significance (Aug 16, 2023)562305
2-44320283-G-A Cystinuria Uncertain significance (Dec 19, 2023)2734178
2-44320298-T-C Cystinuria Conflicting classifications of pathogenicity (Jun 06, 2023)336209
2-44320323-T-G Cystinuria Uncertain significance (Jan 13, 2018)336210
2-44320325-T-C Cystinuria Likely pathogenic (Dec 31, 2018)644169
2-44320329-CA-C Cystinuria • SLC3A1-related disorder Pathogenic/Likely pathogenic (Jul 12, 2023)375410
2-44320329-CAA-C Cystinuria Pathogenic (Aug 09, 2019)953279
2-44320337-C-T Cystinuria • SLC3A1-related disorder Likely benign (Mar 26, 2023)2904920
2-44320348-C-T Cystinuria Conflicting classifications of pathogenicity (Apr 02, 2023)336211
2-44320349-G-A Cystinuria Uncertain significance (Aug 30, 2021)1041951

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PREPLprotein_codingprotein_codingENST00000409936 1445582
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.16e-130.60812562001281257480.000509
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-2.505393991.350.00002114833
Missense in Polyphen143112.271.27381333
Synonymous-2.231741401.240.000007661308
Loss of Function1.582535.10.7120.00000170467

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001680.00168
Ashkenazi Jewish0.001300.00129
East Asian0.0008180.000761
Finnish0.00009250.0000924
European (Non-Finnish)0.0002480.000246
Middle Eastern0.0008180.000761
South Asian0.0006550.000653
Other0.001150.00114

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable serine peptidase whose precise substrate specificity remains unclear. Does not cleave peptides after a arginine or lysine residue. May play a role in the regulation of synaptic vesiscle exocytosis (PubMed:24610330). {ECO:0000269|PubMed:16143824, ECO:0000269|PubMed:16385448, ECO:0000269|PubMed:24610330}.;
Disease
DISEASE: Myasthenic syndrome, congenital, 22 (CMS22) [MIM:616224]: A form of congenital myasthenic syndrome, a group of disorders characterized by failure of neuromuscular transmission, including pre-synaptic, synaptic, and post-synaptic disorders that are not of autoimmune origin. Clinical features include easy fatigability and muscle weakness. CMS22 is an autosomal recessive form characterized by neonatal hypotonia. {ECO:0000269|PubMed:24610330}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.109

Intolerance Scores

loftool
0.0602
rvis_EVS
-0.84
rvis_percentile_EVS
11.48

Haploinsufficiency Scores

pHI
0.374
hipred
N
hipred_score
0.339
ghis
0.646

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.944

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prepl
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); muscle phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
proteolysis;regulation of synaptic vesicle exocytosis
Cellular component
Golgi apparatus;cytosol;cytoskeleton
Molecular function
serine-type endopeptidase activity;protein binding;serine-type exopeptidase activity